{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:53:52Z","timestamp":1775832832649,"version":"3.50.1"},"reference-count":67,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2025.0160","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:26:54Z","timestamp":1759998414000},"source":"Crossref","is-referenced-by-count":1,"title":["The differential diagnosis of thrombocytopenia"],"prefix":"10.3238","author":[{"given":"Wolfgang","family":"Miesbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Stratmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Sonja","family":"Alesci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Chromik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"10.3238\/arztebl.m2025.0160_ref1","doi-asserted-by":"crossref","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.: American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 2019; 3: 3829\u201366.","DOI":"10.1182\/bloodadvances.2019000966"},{"key":"10.3238\/arztebl.m2025.0160_ref2","doi-asserted-by":"crossref","unstructured":"Bizzaro N: EDTA-dependent pseudothrombocytopenia: A clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995; 50: 103\u20139.","DOI":"10.1002\/ajh.2830500206"},{"key":"10.3238\/arztebl.m2025.0160_ref3","doi-asserted-by":"crossref","unstructured":"Kantarjian H, Giles F, List A, et al.: The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer 2007; 109: 1705\u201314.","DOI":"10.1002\/cncr.22602"},{"key":"10.3238\/arztebl.m2025.0160_ref4","doi-asserted-by":"crossref","unstructured":"Kohli R, Chaturvedi S: Epidemiology and clinical manifestations of immune thrombocytopenia. Hamostaseologie 2019; 39: 238\u201349.","DOI":"10.1055\/s-0039-1683416"},{"key":"10.3238\/arztebl.m2025.0160_ref5","doi-asserted-by":"crossref","unstructured":"Arnold DM, Patriquin CJ, Nazy I: Thrombotic microangiopathies: A general approach to diagnosis and management. CMAJ 2017; 189: E153\u2013E9.","DOI":"10.1503\/cmaj.160142"},{"key":"10.3238\/arztebl.m2025.0160_ref6","doi-asserted-by":"crossref","unstructured":"Cornelissen LL, Kreuger AL, Caram-Deelder C, et al.: Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia\u2014a nested case-control study. Ann Hematol 2021; 100: 261\u201371.","DOI":"10.1007\/s00277-020-04298-7"},{"key":"10.3238\/arztebl.m2025.0160_ref7","doi-asserted-by":"crossref","unstructured":"Shaw JL, Nielson CM, Park JK, Marongiu A, Soff GA: The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies. Eur J Haematol 2021; 106: 662\u201372.","DOI":"10.1111\/ejh.13595"},{"key":"10.3238\/arztebl.m2025.0160_ref8","doi-asserted-by":"crossref","unstructured":"Montan\u00e9 E, Ib\u00e1\u00f1ez L, Vidal X, et al.: Epidemiology of aplastic anemia: A prospective multicenter study. Haematologica 2008; 93: 518\u201323.","DOI":"10.3324\/haematol.12020"},{"key":"10.3238\/arztebl.m2025.0160_ref9","doi-asserted-by":"crossref","unstructured":"Borkowski A, Gawry&#347; J, Iwanek G, Dybko J: A family case series of inherited thrombocytopenia. Proc (Bayl Univ Med Cent) 2022; 36: 93\u20135.","DOI":"10.1080\/08998280.2022.2116744"},{"key":"10.3238\/arztebl.m2025.0160_ref10","doi-asserted-by":"crossref","unstructured":"Cuker A, Arepally GM, Chong BH, et al.: American Society of Hematology 2018 guidelines for management of venous thromboembolism: Heparin-induced thrombocytopenia. Blood Adv 2018; 2: 3360\u201392.","DOI":"10.1182\/bloodadvances.2018024489"},{"key":"10.3238\/arztebl.m2025.0160_ref11","doi-asserted-by":"crossref","unstructured":"Reese JA, Li X, Hauben M, et al.: Identifying drugs that cause acute thrombocytopenia: An analysis using 3 distinct methods. Blood 2010; 116: 2127\u201333.","DOI":"10.1182\/blood-2010-03-276691"},{"key":"10.3238\/arztebl.m2025.0160_ref12","doi-asserted-by":"crossref","unstructured":"Cines DB, Levine LD: Thrombocytopenia in pregnancy. Blood 2017; 130: 2271\u20137.","DOI":"10.1182\/blood-2017-05-781971"},{"key":"10.3238\/arztebl.m2025.0160_ref13","doi-asserted-by":"crossref","unstructured":"Fogerty AE: ITP in pregnancy: Diagnostics and therapeutics in 2024. Hematology Am Soc Hematol Educ Program 2024; 2024: 685\u201391.","DOI":"10.1182\/hematology.2024000595"},{"key":"10.3238\/arztebl.m2025.0160_ref14","doi-asserted-by":"crossref","unstructured":"Schaefer-Graf UM, Schmidt M, Sachs U, K\u00fchnert M: Empfehlungen der AGG (Arbeitsgemeinschaft f\u00fcr Geburtshilfe und Pr\u00e4natalmedizin, Sektion Maternale Erkrankungen) zur maternalen Thrombozytopenie in der Schwangerschaft. Geburtsh Frauenheilk 2025; DOI: 10.1055\/a-2500\u20130185.","DOI":"10.1055\/a-2500-0185"},{"key":"10.3238\/arztebl.m2025.0160_ref15","doi-asserted-by":"crossref","unstructured":"Provan D, Arnold DM, Bussel JB, et al.: Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019; 3: 3780\u2013817.","DOI":"10.1182\/bloodadvances.2019000812"},{"key":"10.3238\/arztebl.m2025.0160_ref16","doi-asserted-by":"crossref","unstructured":"Mititelu A, Onis\u00e2i MC, Ro&#537;ca A, Vl&#259;d&#259;reanu AM: Current understanding of immune thrombocytopenia: A review of pathogenesis and treatment options. Int J Mol Sci 2024; 25: 2163.","DOI":"10.3390\/ijms25042163"},{"key":"10.3238\/arztebl.m2025.0160_ref17","doi-asserted-by":"crossref","unstructured":"Anat GG: Current approaches for the diagnosis and management of immune thrombocytopenia. Eur J Intern Med 2023; 108: 18\u201324.","DOI":"10.1016\/j.ejim.2022.11.022"},{"key":"10.3238\/arztebl.m2025.0160_ref18","doi-asserted-by":"crossref","unstructured":"Wei Y, Ji XB, Wang YW, et al.: High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: A prospective multicenter randomized trial. Blood 2016; 127: 296\u2013302.","DOI":"10.1182\/blood-2015-07-659656"},{"key":"10.3238\/arztebl.m2025.0160_ref19","doi-asserted-by":"crossref","unstructured":"Mithoowani S, Gregory-Miller K, Goy J, et al.: High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: A systematic review and meta-analysis. Lancet Haematol 2016; 3: e489\u2013e96.","DOI":"10.1016\/S2352-3026(16)30109-0"},{"key":"10.3238\/arztebl.m2025.0160_ref20","doi-asserted-by":"crossref","unstructured":"Danese E, Montagnana M, Favaloro EJ, Lippi G: Drug-induced thrombocytopenia: Mechanisms and laboratory diagnostics. Semin Thromb Hemost 2020; 46: 264\u201374.","DOI":"10.1055\/s-0039-1697930"},{"key":"10.3238\/arztebl.m2025.0160_ref21","doi-asserted-by":"crossref","unstructured":"George JN, Raskob GE, Shah SR, et al.: Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Intern Med 1998; 129: 886\u201390.","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009"},{"key":"10.3238\/arztebl.m2025.0160_ref22","doi-asserted-by":"crossref","unstructured":"Marini I, Uzun G, Jamal K, Bakchoul T: Treatment of drug-induced immune thrombocytopenias. Haematologica 2022; 107: 1264\u201377.","DOI":"10.3324\/haematol.2021.279484"},{"key":"10.3238\/arztebl.m2025.0160_ref23","doi-asserted-by":"crossref","unstructured":"Liang SX, Pinkevych M, Khachigian LM, Parish CR, Davenport MP, Chong BH: Drug-induced thrombocytopenia: Development of a novel NOD\/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG. Blood 2010; 116: 1958\u201360.","DOI":"10.1182\/blood-2010-02-268326"},{"key":"10.3238\/arztebl.m2025.0160_ref24","doi-asserted-by":"crossref","unstructured":"Solomon CG, Greinacher A: Heparin-induced thrombocytopenia. N Engl J Med 2015; 373: 252\u201361.","DOI":"10.1056\/NEJMcp1411910"},{"key":"10.3238\/arztebl.m2025.0160_ref25","unstructured":"Greinacher A: Heparininduzierte Thrombozytopenie Dtsch Arztebl 2003; 100: A 2220\u20139 [Heft 34\u201335]."},{"key":"10.3238\/arztebl.m2025.0160_ref26","doi-asserted-by":"crossref","unstructured":"Mongirdien&#279; A, Liuiz&#279; A, Ka\u0161auskas A: Novel knowledge about molecular mechanisms of heparin-induced thrombocytopenia type II and treatment targets. Int J Mol Sci 2023; 24: 8217.","DOI":"10.3390\/ijms24098217"},{"key":"10.3238\/arztebl.m2025.0160_ref27","doi-asserted-by":"crossref","unstructured":"Cuker A, Gimotty PA, Crowther MA, Warkentin TE: Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: A systematic review and meta-analysis. Blood 2012; 120: 4160\u20137.","DOI":"10.1182\/blood-2012-07-443051"},{"key":"10.3238\/arztebl.m2025.0160_ref28","doi-asserted-by":"crossref","unstructured":"Larsen EL, Nilius H, Studt JD, et al.: Accuracy of diagnosing heparin-induced thrombocytopenia. JAMA Netw Open 2024; 7: e243786.","DOI":"10.1001\/jamanetworkopen.2024.3786"},{"key":"10.3238\/arztebl.m2025.0160_ref29","doi-asserted-by":"crossref","unstructured":"Marini I, Uzun G, Jamal K, Bakchoul T: Treatment of drug-induced immune thrombocytopenias. Haematologica 2022; 107: 1264\u201377.","DOI":"10.3324\/haematol.2021.279484"},{"key":"10.3238\/arztebl.m2025.0160_ref30","doi-asserted-by":"crossref","unstructured":"Raadsen M, Toit JD, Langerak T, Bussel B van, Gorp E van, Goeijenbier M: Thrombocytopenia in Virus Infections. J Clin Med 2021; 10: 877.","DOI":"10.3390\/jcm10040877"},{"key":"10.3238\/arztebl.m2025.0160_ref31","doi-asserted-by":"crossref","unstructured":"Thandassery RB, Kaabi SA, Soofi ME, et al.: Mean platelet volume, red cell distribution width to platelet count ratio, globulin platelet index, and 16 other indirect noninvasive fibro-sis scores. J Clin Gastroenterol 2016; 50: 518\u201323.","DOI":"10.1097\/MCG.0000000000000489"},{"key":"10.3238\/arztebl.m2025.0160_ref32","doi-asserted-by":"crossref","unstructured":"Tomashek KM, Lorenzi OD, And\u00fajar-P\u00e9rez DA, et al.: Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012\u201315. PLoS Negl Trop Dis 2017; 11: e0005859.","DOI":"10.1371\/journal.pntd.0005859"},{"key":"10.3238\/arztebl.m2025.0160_ref33","unstructured":"Olariu M, Olariu C, Olteanu D: Thrombocytopenia in chronic hepatitis C. J Gastrointestin Liver Dis 2010; 19: 381\u20135."},{"key":"10.3238\/arztebl.m2025.0160_ref34","doi-asserted-by":"crossref","unstructured":"Singh MV, Davidson DC, Kiebala M, Maggirwar SB: Detection of circulating platelet\u2013monocyte complexes in persons infected with human immunodeficiency virus type-1. J Virol Methods 2012; 181: 170\u20136.","DOI":"10.1016\/j.jviromet.2012.02.005"},{"key":"10.3238\/arztebl.m2025.0160_ref35","doi-asserted-by":"crossref","unstructured":"Ahmad A, Ashraf S, Komai S: Are developing countries prepared to face Ebola-like out-breaks? Virol Sin 2015; 30: 234\u20137.","DOI":"10.1007\/s12250-015-3564-9"},{"key":"10.3238\/arztebl.m2025.0160_ref36","doi-asserted-by":"crossref","unstructured":"Miesbach W, Makris M: COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost 2020; 26: 1076029620938149.","DOI":"10.1177\/1076029620938149"},{"key":"10.3238\/arztebl.m2025.0160_ref37","doi-asserted-by":"crossref","unstructured":"Iba T, Levy JH: The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends Cardiovasc Med 2022; 32: 1\u20139.","DOI":"10.1016\/j.tcm.2021.08.012"},{"key":"10.3238\/arztebl.m2025.0160_ref38","doi-asserted-by":"crossref","unstructured":"Cacciola R, Cacciola EG, Vecchio V, Cacciola E: Cellular and molecular mechanisms in COVID-19 coagulopathy: Role of inflammation and endotheliopathy. J Thromb Thrombolysis 2022; 53: 282\u201390.","DOI":"10.1007\/s11239-021-02583-4"},{"key":"10.3238\/arztebl.m2025.0160_ref39","doi-asserted-by":"crossref","unstructured":"Soy M, Atag\u00fcnd\u00fcz P, Atag\u00fcnd\u00fcz I, Sucak GT: Hemophagocytic lymphohistiocytosis: A review inspired by the COVID-19 pandemic. Rheumatol Int 2021; 41: 7\u201318.","DOI":"10.1007\/s00296-020-04636-y"},{"key":"10.3238\/arztebl.m2025.0160_ref40","doi-asserted-by":"crossref","unstructured":"Azzarone B, Veneziani I, Moretta L, Maggi E: Pathogenic mechanisms of vaccine-induced immune thrombotic thrombocytopenia in people receiving Anti-COVID-19 adenoviral-based vaccines: A proposal. Front Immunol 2021; 12: 728513.","DOI":"10.3389\/fimmu.2021.728513"},{"key":"10.3238\/arztebl.m2025.0160_ref41","doi-asserted-by":"crossref","unstructured":"Burn E, Li X, Delmestri A, et al.: Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nat Commun 2022; 13: 7167.","DOI":"10.1038\/s41467-022-34668-w"},{"key":"10.3238\/arztebl.m2025.0160_ref42","doi-asserted-by":"crossref","unstructured":"Rodeghiero F, Cantoni S, Carli G, et al.: Practical recommendations for the management of patients with ITP during the COVID-19 pandemic. Mediterr J Hematol Infect Dis 2021; 13: e2021032.","DOI":"10.4084\/MJHID.2021.032"},{"key":"10.3238\/arztebl.m2025.0160_ref43","unstructured":"Kreuzer KA, Gattermann N, Gebhart J, Goede J, Langer F: Thrombozytopenien. 2023. www.onkopedia.com\/de\/onkopedia\/guidelines\/thrombozytopenien\/@@guideline\/html\/index.html."},{"key":"10.3238\/arztebl.m2025.0160_ref44","doi-asserted-by":"crossref","unstructured":"Giannubilo SR, Marzioni D, Tossetta G, Ciavattini A: HELLP syndrome and differential diagnosis with other thrombotic microangiopathies in pregnancy. Diagnostics (Basel) 2024; 14: 352.","DOI":"10.3390\/diagnostics14040352"},{"key":"10.3238\/arztebl.m2025.0160_ref45","doi-asserted-by":"crossref","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.: The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 2023; 75: 1687\u20131702.","DOI":"10.1002\/art.42624"},{"key":"10.3238\/arztebl.m2025.0160_ref46","doi-asserted-by":"crossref","unstructured":"Audia S, Grienay N, Mounier M, Michel M, Bonnotte B: Evans\u2018 syndrome: From diagnosis to treatment. J Clin Med 2020; 9: 3851.","DOI":"10.3390\/jcm9123851"},{"key":"10.3238\/arztebl.m2025.0160_ref47","doi-asserted-by":"crossref","unstructured":"Trebicka J, Praktiknjo M, Peiffer KH, Pascher A, Schulz MS, Uschner FE: Acute on chronic liver failure. Dtsch Arztebl Int 2025; 122: 96\u2013102.","DOI":"10.3238\/arztebl.m2024.0255"},{"key":"10.3238\/arztebl.m2025.0160_ref48","doi-asserted-by":"crossref","unstructured":"Peck-Radosavljevic M: Thrombocytopenia in chronic liver disease. Liver Int 2017; 37: 778\u201393.","DOI":"10.1111\/liv.13317"},{"key":"10.3238\/arztebl.m2025.0160_ref49","doi-asserted-by":"crossref","unstructured":"Stafylidis C, Diamantopoulos PT, Vlachopoulou D, Antoniadou V: A single-center study of long-term efficacy and discontinuation patterns of thrombopoietin receptor agonists in chronic immune thrombocytopenia. Blood 144 (Suppl 1): 5439.","DOI":"10.1182\/blood-2024-208230"},{"key":"10.3238\/arztebl.m2025.0160_ref50","doi-asserted-by":"crossref","unstructured":"Terrault N, Chen YC, Izumi N, et al.: Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia. Gastroenterology 2018; 155: 705\u201318.","DOI":"10.1053\/j.gastro.2018.05.025"},{"key":"10.3238\/arztebl.m2025.0160_ref51","doi-asserted-by":"crossref","unstructured":"Papageorgiou C, Jourdi G, Adjambri E, et al.: Disseminated intravascular coagulation: An update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost 2018; 24 (9_suppl): 8S\u201328S.","DOI":"10.1177\/1076029618806424"},{"key":"10.3238\/arztebl.m2025.0160_ref52","doi-asserted-by":"crossref","unstructured":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH): Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327\u201330.","DOI":"10.1055\/s-0037-1616068"},{"key":"10.3238\/arztebl.m2025.0160_ref53","doi-asserted-by":"crossref","unstructured":"Zafar A, Naeem F, Khalid MZ, Awan S, Riaz MM, Mahmood SBZ: Comparison of five different disseminated intravascular coagulation criteria in predicting mortality in patients with sepsis. PLoS One 2024; 19: e0295050.","DOI":"10.1371\/journal.pone.0295050"},{"key":"10.3238\/arztebl.m2025.0160_ref54","doi-asserted-by":"crossref","unstructured":"Gando S, Iba T, Eguchi Y, et al.: A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria. Crit Care Med 2006; 34: 625\u201331.","DOI":"10.1097\/01.CCM.0000202209.42491.38"},{"key":"10.3238\/arztebl.m2025.0160_ref55","doi-asserted-by":"crossref","unstructured":"Helms J, Severac F, Merdji H, et al.: Performances of disseminated intravascular coagulation scoring systems in septic shock patients. Ann Intensive Care 2020; 10: 92.","DOI":"10.1186\/s13613-020-00704-5"},{"key":"10.3238\/arztebl.m2025.0160_ref56","doi-asserted-by":"crossref","unstructured":"Iba T, Di Nisio M, Levy JH, Kitamura N, Thachil J: New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: A retrospective analysis of a nationwide survey. BMJ Open 2017; 7: e017046.","DOI":"10.1136\/bmjopen-2017-017046"},{"key":"10.3238\/arztebl.m2025.0160_ref57","doi-asserted-by":"crossref","unstructured":"Bendapudi PK, Hurwitz S, Fry A, et al.: Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: A cohort study. Lancet Haematol 2017; 4: e157\u2013e64.","DOI":"10.1016\/S2352-3026(17)30026-1"},{"key":"10.3238\/arztebl.m2025.0160_ref58","doi-asserted-by":"crossref","unstructured":"Wendt R, Kalbitz S, Otto F, et al.: Diagnosis of hereditary TTP caused by homozygosity for a rare complex ADAMTS13 allele after salmonella infection in a 43-year-old asylum seeker. Front Med (Lausanne) 2021; 8: 639441.","DOI":"10.3389\/fmed.2021.639441"},{"key":"10.3238\/arztebl.m2025.0160_ref59","doi-asserted-by":"crossref","unstructured":"Coppo P, Schwarzinger M, Buffet M, et al.: Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: The French TMA reference center experience. Plos One 2010; 5: e10208.","DOI":"10.1371\/journal.pone.0010208"},{"key":"10.3238\/arztebl.m2025.0160_ref60","doi-asserted-by":"crossref","unstructured":"Riedl M, Fakhouri F, Quintrec ML, et al.: Spectrum of complement-mediated thrombotic microangiopathies: Pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 2014; 40: 444\u201364.","DOI":"10.1055\/s-0034-1376153"},{"key":"10.3238\/arztebl.m2025.0160_ref61","doi-asserted-by":"crossref","unstructured":"V\u00f6lker LA, Brinkkoetter PT, Kn\u00f6bl PN, et al.: Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab. J Thromb Haemost 2020; 18: 3061\u20136.","DOI":"10.1111\/jth.15045"},{"key":"10.3238\/arztebl.m2025.0160_ref62","doi-asserted-by":"crossref","unstructured":"V\u00f6lker LA, Kaufeld J, Balduin G, et al:. Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura. J Thromb Haemost 2023; 21: 559\u201372.","DOI":"10.1016\/j.jtha.2022.11.010"},{"key":"10.3238\/arztebl.m2025.0160_ref63","doi-asserted-by":"crossref","unstructured":"Zheng XL, Al-Housni Z, Cataland SR, et al.: 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura. J Thromb Haemost 2025: S1538\u20137836(25)00360\u20135.","DOI":"10.1016\/j.jtha.2025.06.002"},{"key":"10.3238\/arztebl.m2025.0160_ref64","doi-asserted-by":"crossref","unstructured":"G\u00e4ckler A, Brinkk\u00f6tter PT: [Atypical hemolytic uremic syndrome: Differential diagnosis and therapy\u2014a clinical practice guideline for diagnosis and therapy]. Dtsch Med Wochenschr 2025; 150: 167\u201372.","DOI":"10.1055\/a-2382-6433"},{"key":"10.3238\/arztebl.m2025.0160_ref65","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.: The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms. Leukemia 2022; 36: 1720\u201348.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"10.3238\/arztebl.m2025.0160_ref66","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O, et al.: The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and histiocytic\/dendritic neoplasms. Leukemia 2022; 36: 1703\u201319.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"10.3238\/arztebl.m2025.0160_ref67","doi-asserted-by":"crossref","unstructured":"Kulasekararaj A, Cavenagh J, Dokal I, et al.: Guidelines for the diagnosis and management of adult aplastic anaemia: A British society for haematology guideline. Br J Haematol 2024; 204: 784\u2013804.","DOI":"10.1111\/bjh.19236"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:29:08Z","timestamp":1759998548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":67,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2025.0160","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}